Distinct Gene-expression Profiles Associated with the Susceptibility of Pathogen-specific CD4 T Cells to HIV-1 Infection
Overview
Authors
Affiliations
In HIV infection, CD4 responses to opportunistic pathogens such as Candida albicans are lost early, but CMV-specific CD4 response persists. Little is currently known about HIV infection of CD4 T cells of different pathogen/antigen specificities. CFSE-labeled PBMCs were stimulated with CMV, tetanus toxoid (TT), and C albicans antigens and subsequently exposed to HIV. HIV infection was monitored by intracellular p24 in CFSE(low) population. We found that although TT- and C albicans-specific CD4 T cells were permissive, CMV-specific CD4 T cells were highly resistant to both R5 and X4 HIV. Quantification of HIV DNA in CFSE(low) cells showed a reduction of strong-stop and full-length DNA in CMV-specific cells compared with TT- and C albicans-specific cells. β-Chemokine neutralization enhanced HIV infection in TT- and C albicans-specific cells, whereas HIV infection in CMV-specific cells remained low despite increased entry by β-chemokine neutralization, suggesting postentry HIV restriction by CMV-specific cells. Microarray analysis (Gene Expression Omnibus accession number: GSE42853) revealed distinct transcriptional profiles that involved selective up-regulation of comprehensive innate antiviral genes in CMV-specific cells, whereas TT- and C albicans-specific cells mainly up-regulated Th17 inflammatory response. Our data suggest a mechanism for the persistence of CMV-specific CD4 response and earlier loss of mucosal Th17-associated TT- and C albicans-specific CD4 response in AIDS.
Chronic inflammation degrades CD4 T cell immunity to prior vaccines in treated HIV infection.
Kiessling M, Cole J, Kubel S, Klein P, Korn K, Henry A Nat Commun. 2024; 15(1):10200.
PMID: 39587133 PMC: 11589758. DOI: 10.1038/s41467-024-54605-3.
HIV Expression in Infected T Cell Clones.
Rausch J, Parvez S, Pathak S, Capoferri A, Kearney M Viruses. 2024; 16(1).
PMID: 38257808 PMC: 10820123. DOI: 10.3390/v16010108.
Antigen specificities of HIV-infected cells: A role in infection and persistence?.
Faua C, Fafi-Kremer S, Gantner P J Virus Erad. 2023; 9(2):100329.
PMID: 37440870 PMC: 10334354. DOI: 10.1016/j.jve.2023.100329.
Heeregrave E, Thomas J, van Capel T, de Jong E, Pollakis G, Paxton W Front Immunol. 2023; 14:1107349.
PMID: 37415979 PMC: 10320205. DOI: 10.3389/fimmu.2023.1107349.
HSV-2 triggers upregulation of MALAT1 in CD4+ T cells and promotes HIV latency reversal.
Pierce C, Loh L, Steach H, Cheshenko N, Preston-Hurlburt P, Zhang F J Clin Invest. 2023; 133(11).
PMID: 37079384 PMC: 10232005. DOI: 10.1172/JCI164317.